Andrea Escelsior, Alessio Zizzi, Gaia Dibiase, Luca Ploner, Alessandro Ferrante, Alberto Inuggi, Riccardo Guglielmo, Beatriz Pereira da Silva, Monica Gori, Mario Amore, Georg Northoff, Gianluca Serafini
Visual dysfunction is associated with psychosis-related outcomes, but interpretation depends on visual domain and study design. Current evidence supports a cautious, bidirectional, domain-based framework rather than a single causal pathway from visual impairment to psychosis.
OBJECTIVES: Visual impairment and broader visual-related abnormalities have been implicated in psychosis, but the consistency, specificity, and direction of this association remain unclear. We systematically reviewed evidence linking clinically defined visual impairment, visual-processing abnormalities, oculomotor/visuomotor abnormalities, higher-order visual dysfunction, and psychosis-related outcomes.
METHODS: PubMed/MEDLINE, EMBASE, and PsycINFO were searched according to PRISMA guidelines. Studies were synthesized narratively by design and visual-related domain. An exploratory random-effects meta-analysis was conducted when sufficiently comparable cross-sectional estimates were available for clinically defined or functional visual impairment.
RESULTS: Fifty-six unique studies were included and synthesized across longitudinal or genetically informed, case-control, cross-sectional, and case-report evidence. Longitudinal findings were heterogeneous, with positive, inverse, null, attenuated, and reverse-direction associations. Case-control studies reported abnormalities across retinal/ocular, central visual-system, electrophysiological, oculomotor, subjective, and higher-order visual-cognitive domains, whereas visual-acuity findings were mixed. Cross-sectional studies provided the most consistent evidence for an association between clinically defined or functional visual impairment and psychosis-related outcomes. In the primary meta-analysis of 12 cross-sectional estimates, visual impairment was associated with higher odds of psychosis-related outcomes (OR = 1.98, 95% CI 1.35-2.90). Sensitivity analyses remained positive under broader eligibility criteria and after exclusion of the largest effect estimate. Direction-stratified and hallucination-related analyses also supported a positive association, although smaller subgroups were less precise.
CONCLUSIONS: Visual dysfunction is associated with psychosis-related outcomes, but interpretation depends on visual domain and study design. Current evidence supports a cautious, bidirectional, domain-based framework rather than a single causal pathway from visual impairment to psychosis.